UPEXI INC

Insider Trading & Executive Data

UPXI
NASDAQ
Communication Services
Internet Content & Information

Start Free Trial

Get the full insider signal for UPXI

31 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
31
0 in last 30 days
Buy / Sell (1Y)
31/0
Acquisitions / Dispositions
Unique Insiders (1Y)
6
Active in past year
Insider Positions
9
Current holdings
Position Status
9/0
Active / Exited
Institutional Holders
70
Latest quarter
Board Members
6

Compensation & Governance

Avg Total Compensation
$909012.53
Latest year: 2024
Executives Covered
7
Comp records available
Form 8-K Events (1Y)
2
Personnel Changes (1Y)
2
Bonus Plan Events (1Y)
1
Organization Changes (1Y)
0
Board Appointments (1Y)
2
Board Departures (1Y)
0

Restricted Sales

Form 144 Filings (1Y)
0
Form 144 Insiders (1Y)
0
Planned Sale Shares (1Y)
0
Planned Sale Value (1Y)
$0.00
Price
$0.68
Market Cap
$46.0M
Volume
34,058.838
EPS
N/A
Revenue
$8.1M
Employees
59
About UPEXI INC

Company Overview

Upexi is a dual-business company combining a long-only Solana (SOL) digital-asset treasury with ownership, manufacturing and distribution of consumer brands (LuckyTail, PRAX, Cure Mushrooms, Moonwlkr, Gumi Labs) focused on wellness, pet care and cannabinoid products. Since early 2025 the company has reallocated a large portion of its balance sheet into SOL (roughly $253 million held with BitGo at reported prices) and currently stakes about 95% of its holdings to generate yield, while operating end-to-end manufacturing and DTC/distribution from facilities in Florida. Recent financials show a materially restructured revenue base (revenue down 43% as recommerce was divested) and a mix of staking revenue plus product margins, with G&A up 76% driven in part by higher corporate compensation and public-company costs. Key operational risks are SOL price volatility, validator/custody concentration, regulatory oversight of digital assets and product-specific regulation (FDA/FTC/USDA for hemp/CBD).

Executive Compensation Practices

Compensation appears increasingly tied to both corporate and treasury outcomes: management disclosed materially higher corporate compensation as G&A rose, and future pay programs are likely to incorporate digital-asset treasury performance (SOL price movements, staking revenue, slashing/validator performance) alongside traditional operating metrics (gross margin, inventory turnover, DTC growth and working capital). Given aggressive capital raises, convertible instruments, warrants (including those issued to asset manager GSR) and public-company transition costs, long-term incentives are likely to include equity, options and warrants—and may increasingly contemplate crypto-linked metrics or NAV-based bonus gates to align pay with treasury returns. The company’s reliance on an external asset manager with fees and warrant economics creates a structural drag on net treasury returns that could influence target-setting and payout outcomes for executives. Regulatory uncertainty around digital assets and product categories suggests boards may build compliance- and risk-mitigation vesting conditions (e.g., clawbacks, blackout periods or hedging prohibitions) into executive packages.

Insider Trading Considerations

Insider trading patterns at Upexi may reflect two distinct exposures: equity/warrant/convertible economics tied to the corporate business and direct sensitivity to SOL price and staking announcements; look for clustering of insider activity around fundraising events, private placements, convertible issuances and staking revenue disclosures. Concentration of custodial holdings (BitGo primary) and relatively limited custodial insurance elevate the materiality of adverse custody or slashing events, which could prompt rapid market reactions and increase the likelihood of pre- or post-event insider sales or hedging (subject to policy). Monitor filings for insider participation in capital raises, transfers related to warrants or option exercises, and any related-party arrangements (e.g., asset-manager warrants to GSR) that change potential insider dilution or incentives. Finally, evolving federal/state crypto regulation and product-specific oversight (CBD/hemp) can create formal blackout windows, additional disclosure obligations and heightened enforcement risk that may constrain or change timing of insider transactions.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for UPEXI INC and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime